June 29, 2022
Ono Pharmaceutical said on June 28 that it has signed an agreement to expand its 2018 collaboration deal with San Diego biotech Fate Therapeutics for the discovery of iPSC-derived CAR-T cell therapies. Under the new pact, the Japanese company aims...read more